NO912940D0 - Immunundertrykkende middel og fremgangsmaate for fremstilling av samme. - Google Patents

Immunundertrykkende middel og fremgangsmaate for fremstilling av samme.

Info

Publication number
NO912940D0
NO912940D0 NO912940A NO912940A NO912940D0 NO 912940 D0 NO912940 D0 NO 912940D0 NO 912940 A NO912940 A NO 912940A NO 912940 A NO912940 A NO 912940A NO 912940 D0 NO912940 D0 NO 912940D0
Authority
NO
Norway
Prior art keywords
alkyl
immune
preparing
procedure
same
Prior art date
Application number
NO912940A
Other languages
English (en)
Other versions
NO912940L (no
Inventor
Hiroshi Nagase
Koji Kawai
Shu Matsumoto
Takashi Endoh
Yoshiaki Katsura
Kohei Arakawa
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO912940D0 publication Critical patent/NO912940D0/no
Publication of NO912940L publication Critical patent/NO912940L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Light Receiving Elements (AREA)
  • Amplifiers (AREA)
NO91912940A 1989-11-28 1991-07-29 Immunundertrykkende middel og fremgangsmaate for fremstilling av samme. NO912940L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30849189 1989-11-28
JP32216089 1989-12-11
JP32694189 1989-12-15
PCT/JP1990/001541 WO1991007966A1 (fr) 1989-11-28 1990-11-28 Immunosuppresseur et procede de preparation d'un tel medicament

Publications (2)

Publication Number Publication Date
NO912940D0 true NO912940D0 (no) 1991-07-29
NO912940L NO912940L (no) 1991-07-29

Family

ID=27338974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912940A NO912940L (no) 1989-11-28 1991-07-29 Immunundertrykkende middel og fremgangsmaate for fremstilling av samme.

Country Status (14)

Country Link
US (1) US5332818A (no)
EP (1) EP0456833B1 (no)
JP (1) JP2906654B2 (no)
KR (1) KR940008032B1 (no)
AT (1) ATE119039T1 (no)
AU (1) AU639053B2 (no)
CA (1) CA2045481C (no)
DE (1) DE69017434T2 (no)
DK (1) DK0456833T3 (no)
ES (1) ES2069100T3 (no)
FI (1) FI913583A0 (no)
GR (1) GR3015266T3 (no)
NO (1) NO912940L (no)
WO (1) WO1991007966A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852030A (en) * 1992-09-29 1998-12-22 Toray Industries, Inc. Indole derivatives, process for producing the same and medicinal uses of the same
KR100301093B1 (ko) * 1992-09-29 2001-10-22 히라이 가쯔히꼬 인돌유도체,그제조방법및그의약용도
DE69318710T2 (de) * 1992-12-22 1998-09-10 Toray Industries Antitussivum
US5464841A (en) * 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
SE9304236D0 (sv) * 1993-12-22 1993-12-22 Astra Ab New use
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
SE9401728D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds II
US5578725A (en) * 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
EP0880526B1 (en) 1996-01-10 2002-12-18 GlaxoSmithKline S.p.A. Heterocycle-condensed morphinoid derivatives (ii)
JP4110579B2 (ja) * 1997-01-16 2008-07-02 東レ株式会社 インドロモルヒナン誘導体および脳障害治療・予防剤
AU6520198A (en) * 1997-03-31 1998-10-22 Toray Industries, Inc. Quinolinomorphinane derivatives and medicinal use thereof
US6359111B1 (en) 1998-05-28 2002-03-19 Neorx Corporation Opioid receptor targeting
US7232829B2 (en) 2001-04-06 2007-06-19 Regents Of The University Of Minnesota Therapeutic compounds and methods
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
AU2002305323A1 (en) 2001-05-04 2002-11-18 Tularik Inc. Fused heterocyclic compounds
AU2003205332A1 (en) * 2002-01-25 2003-09-02 Philip S. Portoghese Selective analgesic agents
US20060052409A1 (en) * 2002-07-11 2006-03-09 Koji Kawai Therapeutic or preventive agent for nausea/vomiting
KR20050103184A (ko) 2002-11-06 2005-10-27 암젠 인코포레이션 융합된 헤테로사이클릭 화합물들
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN1298718C (zh) * 2005-03-18 2007-02-07 中国科学院上海有机化学研究所 C环连接有吡嗪环的青藤碱衍生物、合成方法及其用途
US20070185145A1 (en) * 2006-02-03 2007-08-09 Royds Robert B Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443605A (en) * 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases

Also Published As

Publication number Publication date
CA2045481C (en) 1995-11-14
DE69017434D1 (de) 1995-04-06
DK0456833T3 (da) 1995-05-01
FI913583A0 (fi) 1991-07-26
KR940008032B1 (ko) 1994-09-01
WO1991007966A1 (fr) 1991-06-13
EP0456833A1 (en) 1991-11-21
EP0456833B1 (en) 1995-03-01
JPH03223288A (ja) 1991-10-02
CA2045481A1 (en) 1991-05-29
AU639053B2 (en) 1993-07-15
AU6876891A (en) 1991-06-26
EP0456833A4 (en) 1992-03-18
US5332818A (en) 1994-07-26
JP2906654B2 (ja) 1999-06-21
KR920700643A (ko) 1992-08-10
ATE119039T1 (de) 1995-03-15
ES2069100T3 (es) 1995-05-01
DE69017434T2 (de) 1995-06-29
NO912940L (no) 1991-07-29
GR3015266T3 (en) 1995-06-30

Similar Documents

Publication Publication Date Title
NO912940L (no) Immunundertrykkende middel og fremgangsmaate for fremstilling av samme.
RU93004893A (ru) Производные метиленоксиндола и способ их получения
DE69003397T2 (de) Cyclische Aminverbindungen und ihre Verwendung.
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
HU9202199D0 (en) A new medical preparative containing benzomorphane
DK398289D0 (da) Anvendelse af 2-amino-4-morpholino-6-propyl-1,3,5-triaziner til fremstilling af et laegemiddel mod aeldning og demens
DE3688917T2 (de) Derivate eines Aminoketons.
MX9207429A (es) Nuevo uso de derivados de aminoacido.
DK571786A (da) Cephalosporinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler med indhold heraf
DE69017404T2 (de) Diamantbeschichteter Sinterkörper und Verfahren zu seiner Herstellung.
DE3786642D1 (de) Verwendung eines ueberzugsmittels.
ATE79371T1 (de) Derivate des cysteins, verfahren zur herstellung und verwendung davon.
DE69019610D1 (de) Cyclische Derivate des Amidinylthiocarbapenems.
IT8919814A0 (it) Dispositivo di bloccaggio e regolazione, particolarmente per compassi da disegnatore.
KR900009187A (ko) 고인성 탄화규소질 소결체의 제조방법
IT1218776B (it) Compasso per capisaldi planoaltimetrici di poligonale, per gallerie o canalizzazioni, e suo metodo d'uso
IT227568Y1 (it) Strumento misuratore per uso ortodontico.
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.